iSBTc 22nd Annual Meeting

November 2 - 4, 2007
Seaport World Trade Center
Boston, Massachusetts

The International Society for Biological Therapy of Cancer (iSBTc) held its 22nd Annual Meeting at the Seaport World Trade Center from November 2 - 4 in Boston, Massachusetts. The 22nd Annual Meeting attracted 450 attendees consisting of basic and clinical investigators from academia, industry and regulatory agencies from the U.S., Europe and Asia, and highlighted the latest cutting-edge developments in tumor immunology and the biological therapy of cancer.

The Annual Meeting featured an interactive environment that facilitated productive discourse among clinicians, researchers, students, post-doctoral fellows, and allied health professionals from the US, Europe, Asia and beyond. The meeting included over 50 high-quality scientific lectures and 135 posters related to:

  • Angiogenesis and Vascular Therapies
  • Cellular Therapies
  • Characterizing the Host Response to Cancer
  • Combination Therapy for Cancer
  • Cytokines
  • Immunoregulation and Mediated Tolerance
  • Inflammation and Innate Immunity
  • New Agents
  • Tumor Microenvironment
  • Tumor Recognition / Immune Evasion
  • Vaccines / Dendritic Cells

Annual Meeting Organizers

George Coukos, MD, PhD
University of Pennsylvania Medical Center
F. Stephen Hodi, MD
Dana-Farber Cancer Institute
James C. Yang, MD
National Cancer Institute